NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO)

292 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q2 2022.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 117,343,229 shares of 129,668,560 outstanding shares and own 90.49% of the company stock.
Largest 10 shareholders include BlackRock Inc. (21,030,127 shares), VANGUARD GROUP INC (13,316,401 shares), WELLINGTON MANAGEMENT GROUP LLP (6,522,668 shares), BROWN ADVISORY INC (5,767,650 shares), STATE STREET CORP (4,100,358 shares), Assenagon Asset Management S.A. (3,611,674 shares), GOLDMAN SACHS GROUP INC (3,415,395 shares), First Light Asset Management, LLC (2,715,487 shares), FEDERATED HERMES, INC. (2,676,036 shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (2,295,683 shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.